Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Vora

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
JACC. Cardiovascular Interventions|February 22, 2025
Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic StenosisTayyab Shah, Zhiyuan Zhang, Haashim Shah, et al.
The New England Journal of Medicine|March 19, 2019
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial FibrillationRenato D Lopes, Gretchen Heizer, Ronald Aronson, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Breaking Down Barriers to Transcatheter Aortic Valve ReplacementAmit N Vora, Wayne B Batchelor, Konstantinos Dean Boudoulas, et al.
Clinical Lymphoma|November 15, 2001
Autologous stem-cell transplantation for poor-risk and relapsed intermediate- and high-grade non-Hodgkin's lymphomaA Nademanee, A Molina, A Dagis, et al.
Clinical Trials (London, England)|February 1, 2017
RejoinderThomas R Fleming, David L DeMets, Matthew T Roe, et al.
Clinical Trials (London, England)|April 1, 2017
Data monitoring committees: Promoting best practices to address emerging challengesThomas R Fleming, David L DeMets, Matthew T Roe, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2003
A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcomeH C Fung, A Stein, M l Slovak, et al.
Circulation. Cardiovascular Interventions|June 20, 2023
Racial Differences in Presentation and Outcomes After Peripheral Arterial Interventions: Insights From the NCDR-PVI RegistryHoward M Julien, Yongfei Wang, Jeptha P Curtis, et al.
JACC. Cardiovascular Interventions|March 15, 2023
Clinical Impact of Standardized TAVR Technique and Care Pathway: Insights From the Optimize PRO StudyKendra J Grubb, Hemal Gada, Suneet Mittal, et al.
JACC. Cardiovascular Interventions|June 30, 2025
30-Day and 1-Year Outcomes From the Optimize PRO TAVR Evolut FX Addendum StudyHemal Gada, Ramzi F Khalil, Stanley J Chetcuti, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
JACC. Cardiovascular Interventions|February 22, 2025
Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic StenosisTayyab Shah, Zhiyuan Zhang, Haashim Shah, et al.
The New England Journal of Medicine|March 19, 2019
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial FibrillationRenato D Lopes, Gretchen Heizer, Ronald Aronson, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Breaking Down Barriers to Transcatheter Aortic Valve ReplacementAmit N Vora, Wayne B Batchelor, Konstantinos Dean Boudoulas, et al.
Clinical Lymphoma|November 15, 2001
Autologous stem-cell transplantation for poor-risk and relapsed intermediate- and high-grade non-Hodgkin's lymphomaA Nademanee, A Molina, A Dagis, et al.
Clinical Trials (London, England)|February 1, 2017
RejoinderThomas R Fleming, David L DeMets, Matthew T Roe, et al.
Clinical Trials (London, England)|April 1, 2017
Data monitoring committees: Promoting best practices to address emerging challengesThomas R Fleming, David L DeMets, Matthew T Roe, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2003
A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcomeH C Fung, A Stein, M l Slovak, et al.
Circulation. Cardiovascular Interventions|June 20, 2023
Racial Differences in Presentation and Outcomes After Peripheral Arterial Interventions: Insights From the NCDR-PVI RegistryHoward M Julien, Yongfei Wang, Jeptha P Curtis, et al.
JACC. Cardiovascular Interventions|March 15, 2023
Clinical Impact of Standardized TAVR Technique and Care Pathway: Insights From the Optimize PRO StudyKendra J Grubb, Hemal Gada, Suneet Mittal, et al.
JACC. Cardiovascular Interventions|June 30, 2025
30-Day and 1-Year Outcomes From the Optimize PRO TAVR Evolut FX Addendum StudyHemal Gada, Ramzi F Khalil, Stanley J Chetcuti, et al.
Pageof 16